Talis Biomedical TLIS Stock
Talis Biomedical Price Chart
Talis Biomedical TLIS Financial and Trading Overview
| Talis Biomedical stock price | 8.5 USD |
| Previous Close | 0.44 USD |
| Open | 0.47 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 1000 |
| Day's Range | 0.44 - 0.49 USD |
| 52 Week Range | 0.42 - 1.2 USD |
| Volume | 81.12K USD |
| Avg. Volume | 120.41K USD |
| Market Cap | 12.12M USD |
| Beta (5Y Monthly) | 1.086452 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -34.12 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.35 USD |
TLIS Valuation Measures
| Enterprise Value | -86310360 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.20688073 |
| PEG Ratio (5 yr expected) | 0 |
| Price/Sales (ttm) | 4.264084 |
| Price/Book (mrq) | 0.11002684 |
| Enterprise Value/Revenue | -30.359 |
| Enterprise Value/EBITDA | 0.97 |
Trading Information
Talis Biomedical Stock Price History
| Beta (5Y Monthly) | 1.086452 |
| 52-Week Change | -46.81% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.2 USD |
| 52 Week Low | 0.42 USD |
| 50-Day Moving Average | 0.49 USD |
| 200-Day Moving Average | 0.58 USD |
TLIS Share Statistics
| Avg. Volume (3 month) | 120.41K USD |
| Avg. Daily Volume (10-Days) | 110.45K USD |
| Shares Outstanding | 26.88M |
| Float | 14.29M |
| Short Ratio | 1.1 |
| % Held by Insiders | 10.17% |
| % Held by Institutions | 47.00% |
| Shares Short | 181.6K |
| Short % of Float | 1.60% |
| Short % of Shares Outstanding | 0.67% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3432.14% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -33.54% |
| Return on Equity (ttm) | -62.50% |
Income Statement
| Revenue (ttm) | 2.84M USD |
| Revenue Per Share (ttm) | 0.11 USD |
| Quarterly Revenue Growth (yoy) | -61.79% |
| Gross Profit (ttm) | N/A |
| EBITDA | -88935000 USD |
| Net Income Avi to Common (ttm) | -97792000 USD |
| Diluted EPS (ttm) | -3.35 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 112.96M USD |
| Total Cash Per Share (mrq) | 4.2 USD |
| Total Debt (mrq) | 14.71M USD |
| Total Debt/Equity (mrq) | 13.36 USD |
| Current Ratio (mrq) | 10.339 |
| Book Value Per Share (mrq) | 4.099 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -72843000 USD |
| Levered Free Cash Flow (ttm) | -43293000 USD |
Profile of Talis Biomedical
| Country | United States |
| State | CA |
| City | Redwood City |
| Address | 3400 Bridge Parkway |
| ZIP | 94065 |
| Phone | 650 433 3000 |
| Website | https://talisbio.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 102 |
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also develops Talis One tests for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A and influenza B. The company was incorporated in 2013 and is headquartered in Redwood, California.
Q&A For Talis Biomedical Stock
What is a current TLIS stock price?
Talis Biomedical TLIS stock price today per share is 8.5 USD.
How to purchase Talis Biomedical stock?
You can buy TLIS shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Talis Biomedical?
The stock symbol or ticker of Talis Biomedical is TLIS.
Which industry does the Talis Biomedical company belong to?
The Talis Biomedical industry is Medical Devices.
How many shares does Talis Biomedical have in circulation?
The max supply of Talis Biomedical shares is 1.82M.
What is Talis Biomedical Price to Earnings Ratio (PE Ratio)?
Talis Biomedical PE Ratio is now.
What was Talis Biomedical earnings per share over the trailing 12 months (TTM)?
Talis Biomedical EPS is -34.12 USD over the trailing 12 months.
Which sector does the Talis Biomedical company belong to?
The Talis Biomedical sector is Healthcare.
Talis Biomedical TLIS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}